Federal Judge Limits Groq Trademark Dispute in Ongoing Legal Battle with Endocrinologist

A recent trademark dispute has emerged between Groq, a company known for its work in generative artificial intelligence inference chips, and a New York-based endocrinologist who has renamed her company “Groq Health.” A federal judge in Manhattan has ruled that the court does not have the authority to instruct the U.S. Patent and Trademark Office to dismiss pending trademark applications. This decision effectively dismisses some of the counterclaims made by Groq against Groq Health in this ongoing legal conflict. Further details of the court’s decision and the implications for both parties involved can be accessed through the original article on Law360.